Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core - Grimm, Juliane (Verfasser); Bhayadia, Raj (Verfasser); Gack, Lucie (Verfasser); Heckl, Dirk (Verfasser); Klusmann, Jan-Henning (Verfasser) (Springer Nature, 2022)